Anders Ullman
CIK 1836816 · last filed 2025-10-08
Anders Ullman is a corporate insider who has filed 9 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for VRNA, was dated Oct 8, 2025. Across all open-market trades the lifetime net is −$20.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
-$20.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$20.9K | 9 | 2025-10-08 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-08 | Verona Pharma plc (VRNA) Delisted | Mixed | −358,856 | $0 | EDGAR |
| 2025-08-05 | Verona Pharma plc (VRNA) Delisted | Exer (M) | +24,000 | $0 | EDGAR |
| 2025-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-30 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-05 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −12,056 | -$10.1K | EDGAR |
| 2021-02-03 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −10,800 | -$10.7K | EDGAR |